Mutant IDH1-IN-2

CAS No. 1429176-69-1

Mutant IDH1-IN-2( —— )

Catalog No. M26311 CAS No. 1429176-69-1

Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of 16.6 nM in Fluorescence biochemical assay, IC50 of <22 nM in LS-MS biochemical assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 Get Quote
10MG 372 Get Quote
25MG 623 Get Quote
50MG 887 Get Quote
100MG 1197 Get Quote
500MG 2394 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Mutant IDH1-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of 16.6 nM in Fluorescence biochemical assay, IC50 of <22 nM in LS-MS biochemical assay.
  • Description
    Mutant IDH1-IN-2 is a inhibitor of mutant Isocitrate dehydrogenase (IDH) proteins, with IC50 of 16.6 nM in Fluorescence biochemical assay, IC50 of <22 nM in LS-MS biochemical assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    IDH
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1429176-69-1
  • Formula Weight
    459.542
  • Molecular Formula
    C24H31F2N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (108.81 mM)
  • SMILES
    CC(C)[C@H]1COC(=O)N1c1ccnc(N[C@@H](C)c2ccc(CN3CCC(F)(F)CC3)cc2)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shi Q, Lu L, Lei Y, He Y, Chen J. Gland Origin and Electroantennogram Activity of Volatile Compounds in Ghost Ants, Tapinoma melanocephalum (Hymenoptera: Formicidae) and Behavioral Response to (Z)-9-Nonadecene. Environ Entomol. 2017 Dec 8;46(6):1374-1380.
molnova catalog
related products
  • Enasidenib

    An orally available, selective, potent inhibitor of mutant IDH2 with IC50s of 100-400 nM for IDH2R140Q homodimer.

  • Vorasidenib

    Vorasidenib (AG-881) is a potent, selective and orally bioavailable pan-IDH (isocitrate dehydrogenase) mutant inhibitor for treatment of AML.

  • IDH305

    IDH 305 (IDH305)?is a potent, selective, brain penetrant mutant IDH1 inhibitor with IC50 of 18 and 28 nM for IDH1 R132H and R132C.